scholarly journals PCV71 CLINICAL AND ECONOMIC PROFILE OF PATIENTS WITH ACUTE AND CHRONIC HEART FAILURE IN USUAL CLINICAL PRACTICE

2019 ◽  
Vol 22 ◽  
pp. S132
Author(s):  
A. Sicras-Mainar ◽  
R. Navarro-Artieda ◽  
J.L. Enriquez
2020 ◽  
Vol 2 (3) ◽  
pp. 40-57
Author(s):  
Gennadiy Hubulava ◽  
Kirill L. Kozlov ◽  
Andrey N. Bogomolov ◽  
Aleksey Volkov ◽  
Viktor N. Fedorets ◽  
...  

Chronic heart failure (CHF) is a widespread disease associated with high rates of disability and mortality, as well as a decrease in the quality of life. Moreover, the vast majority of patients are elderly and senile. Modern surgical methods of treating heart failure are able to increase the duration and quality of life of such patients, however, the need far exceeds the volume of this care, and some highly effective methods common in Western countries are still not used in Russian clinical practice. Elderly age is a risk factor for the development of senile asthenia (frailty) and concomitant pathology. Large abdominal surgery is often contraindicated for patients with signs of senile asthenia, and the method of choice in patients with severe heart failure is the implantation of devices for long-term mechanical circulatory support (LT-MCS). After implantation of LT-MCS, a regression of signs of senile asthenia may be observed. The topic of an integrated approach to non-drug treatment of heart failure in elderly and senile patients in Russia has not been studied enough. In particular, the implantation of LT-MCS is not used in Russian clinical practice, while in many Western countries for many years it has been the main and most effective treatment for severe heart failure. Systematization of the available up-to-date information on this topic could help increase the duration and quality of life of patients with severe heart failure.


2014 ◽  
Vol 14 (4) ◽  
pp. 333-333
Author(s):  
Antonino Di Franco ◽  
Filippo M. Sarullo ◽  
Ylenia Salerno ◽  
Stefano Figliozzi ◽  
Rossella Parrinello ◽  
...  

Heart Asia ◽  
2010 ◽  
Vol 2 (1) ◽  
pp. 24-27 ◽  
Author(s):  
S. Fu ◽  
J. Zhang ◽  
X. Gao ◽  
Y. Xia ◽  
R. Ferrelli ◽  
...  

2016 ◽  
Vol 13 (1) ◽  
pp. 52-57
Author(s):  
A I Ponomareva ◽  
O G Kompaniets ◽  
R M Linchak ◽  
G S Ivanchura

The purpose of the study is to determine the spectrum used drugsslows the heart rate in patients with arterial hypertension and chronic heart failure in clinical practice and compliance of prescribing with clinical guidelines.Materials and methods. Consistently formed a retrospective sample of medical records of patients with arterial hypertension and chronic heart failure. Used sources of primary medical documentation for 2012-2015 (320 patients). Estimated the amount and quality therapyslows the heart ratein patients with arterial hypertension and chronic heart failure.Results and discussion. b-blockers prescribed for 72.5% of patients. Calcium antagonists range recommended by 13.1%. On the background of optimal doses of b-blockers in patients with arterial hypertension and chronic heart failure with the exile faction of less than 40 and heart rate more than 70 BPM, ivabradine is not assigned in 81.3% of patients, although it is in these situations of particular urgency is the drug given its bright positive effect on hard end points, proved in international multicenter trials.


2021 ◽  
Vol 2 (2) ◽  
pp. 104-110
Author(s):  
M. M. Batyushin ◽  
A. A. Vachugova ◽  
S. R. Gilyarevskiy ◽  
I. S. Dzherieva ◽  
N. A. Zakaryaeva ◽  
...  

At online scientific expert meeting of the South region held on October 3, 2020, the results of the international multicenter study EMPEROR-Reduced were discussed. Number of proposals and recommendations were adopted for the further study of the cardiovascular and renal effects of empagliflozin, its use in clinical practice in patients with chronic heart failure.


Sign in / Sign up

Export Citation Format

Share Document